Despite rapid advances in modern medical technology and significant improvements in
survival rates of many cancers, pancreatic cancer is still a highly lethal gastrointestinal …

Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor
prognosis and rising incidence. Late detection and a particularly aggressive biology are the …

Malignant tumors are often multifactorial. Epidemiological studies have shown that
hyperglycemia raises the prevalence and mortality of certain malignancies, like breast, liver …

Research on obesity-and diabetes mellitus (DM)-related carcinogenesis has expanded
exponentially since these two diseases were recognized as important risk factors for …

Background Pancreatic cancer (PC) is among foremost causes of cancer related deaths
worldwide due to generic symptoms, lack of effective screening strategies and resistance to …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal
cancers, with a five-year survival rate of around 5% to 8%. To date, very few available drugs …

Diabetic wounds have poor healing outcomes due to the presence of numerous pathogens
and a dysregulated immune response. Group B Streptococcus (GBS) is commonly isolated …

The association of cancer and diabetes mellitus (DM) has been studied for decades.
Hyperglycemia and the imbalance of hormones are factors that contribute to the molecular …

Pancreatic cancer is one of the leading determinants of global cancer mortality, and its
incidence is predicted to increase, to become in 2030 the second most common cause of …

Abstract Fibroblast growth factor 21 (FGF21) plays an important role in regulating glucose
and lipid metabolism, but its role in cancer is less well-studied. We aimed to investigate the …